Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel Imaging Markers of Innate Immune Activation in Secondary Progressive Multiple Sclerosis

NCT05357833 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.

NCT NCT05357833
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05357833 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel Imaging Markers of Innate Immune Activation in Secondary Progressive Multiple Sclerosis
Lead sponsor
University of Utah
Phase
Phase 1
Overall status
Completed
Start date
June 1, 2022
Completion date
September 1, 2023
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis, multiple sclerosis, secondary progressive, secondary progressive multiple sclerosis